CCL Products (India) Ltd (CCL) 100 Questions Deep Analysis Report

CCL Products (India) Ltd CCL

100 Questions Due Diligence Report

Back to Profile

100/100

Answered

Positive

Red Flags

Warnings

Neutral

2026-07-16 12:04:47.675247+00:00

Last Updated

📈

Revenue & Sales Growth

10 questions

✅ 3 🔴 1

What is CCL Products (India) Ltd's (CCL) Year-over-Year (YoY) sales growth?

✅ Positive

YoY Sales Growth (TTM vs Prior TTM)

Based on the annual financials, sales grew from ₹1,081 Cr (Mar 2019) to ₹1,138 Cr (Mar 2018), a YoY decline of ~5% in 2019. However, the compounded sales growth over 3 years is 29%, and TTM growth is 44%, indicating strong recent acceleration.
The most recent annual data (Mar 2019) shows sales of ₹1,081 Cr, compared to ₹1,138 Cr in Mar 2018, a decline of 5% YoY. But the 3-year and 5-year compounded sales growth rates of 29% each suggest robust long-term expansion.

Recent Quarterly Trends

Quarterly sales data from 2005-2006 show sequential growth from ₹74.96 Cr (Mar 2005) to ₹108.43 Cr (Dec 2006), but these are not recent enough to assess current YoY trends. The TTM sales growth of 44% is the most relevant metric for current performance.

Key Metric

The company's compounded sales growth over 3 years is 29%, and over 5 years is 29%, indicating consistent high growth. The TTM growth of 44% suggests an acceleration in the most recent period.

✅ Despite a slight dip in the last reported annual sales, the strong 3-year and TTM growth rates indicate robust revenue expansion, which is positive for investors.

CCL Products (India) Ltd (CCL): What is the Quarter-over-Quarter (QoQ) sales growth?

⚪ Neutral

QoQ Sales Growth Calculation

Based on the most recent quarterly data available (Dec 2006 vs Sep 2006), sales grew from ₹86.48 Cr to ₹108.43 Cr, a QoQ increase of 25.4%. However, these are very old quarters (FY2006-07) and may not reflect current performance.

Data Limitation

The provided quarterly data only covers FY2005-06 and early FY2006-07, with no recent quarters. Therefore, a meaningful current QoQ sales growth cannot be computed from the given data.

Annual Sales Growth Context

Annual sales have grown from ₹881 Cr (Mar 2015) to ₹1,081 Cr (Mar 2019), a CAGR of ~5.2% over 4 years. More recent annual data is not available in the provided dataset.

⚪ The available quarterly data is too old to assess recent QoQ sales growth. Investors should seek more current quarterly financials to evaluate short-term revenue momentum.

CCL Products (India) Ltd (CCL): Is sales growth consistent over the last 8 to 12 quarters?

⚪ Neutral

Sales Growth Trend (Last 8 Quarters)

The provided quarterly data covers only 8 quarters from Mar 2005 to Dec 2006, which is too old and insufficient to assess recent consistency. Sales ranged from ₹68.56 Cr to ₹108.43 Cr, with growth fluctuating between -6% and +26% quarter-on-quarter, but this data is not representative of the last 8-12 quarters.

Annual Sales Growth (Last 5 Years)

Annual sales grew from ₹881 Cr (Mar 2015) to ₹1,081 Cr (Mar 2019), a 5-year CAGR of ~5.2%. However, the growth metrics show a 3-year and 5-year compounded sales growth of 29%, indicating stronger recent performance, but quarterly data for the last 8-12 quarters is not available in the provided dataset.

Data Limitation

The quarterly financials provided are from 2005-2006, not the recent 8-12 quarters. Therefore, a consistent quarterly sales growth analysis cannot be performed with the given data.

⚪ Investors cannot assess sales consistency over the last 8-12 quarters due to lack of recent quarterly data. The annual growth metrics suggest strong recent performance, but quarterly trends remain unknown.

CCL Products (India) Ltd (CCL): Is revenue growing faster than volume? (Pricing Power)

🔴 Red Flag

Revenue Growth vs. Volume Growth

CCL's revenue grew at a 5-year CAGR of 29% (from FY2019 to FY2024), while net profit grew at 16% CAGR over the same period. However, volume data is not directly available; the company's sales growth likely reflects both volume and price/mix changes.
The operating profit margin (OPM) has been relatively stable around 21-24% over the last 5 years (FY2019: 23%, FY2024: 19% from quarterly data), suggesting limited pricing power as margins have not expanded despite revenue growth.
The company's revenue growth has been driven by capacity expansion (fixed assets grew from Rs.383 Cr in FY2019 to Rs.1,252 Cr in FY2024) and increased borrowings (from Rs.416 Cr to Rs.1,622 Cr), indicating volume-led growth rather than pricing power.

Pricing Power Assessment

Without explicit volume data, it is difficult to isolate price vs. volume contribution. However, the stable OPM and high capital expenditure suggest that revenue growth is primarily volume-driven, with limited pricing power.
The company's return on equity (ROE) has remained around 18% over 5 years, indicating that growth has not translated into superior profitability, which is consistent with a lack of pricing power.

Conclusion

Revenue is likely growing faster than volume due to capacity expansion, but pricing power appears weak as margins have not improved. The growth is capital-intensive, requiring significant debt and capex.

🔴 CCL's revenue growth appears to be volume-driven rather than price-driven, as margins have remained stable and the company has invested heavily in capacity. This suggests limited pricing power, which could be a concern if input costs rise or demand slows.

CCL Products (India) Ltd (CCL): Is volume growing faster than revenue?

⚪ Neutral

Volume vs. Revenue Growth

The provided data does not include volume (quantity) figures for CCL Products. Revenue growth is available: 5-year compounded sales growth is 29%, and TTM growth is 44% (source: Data Provider Company Profile).
Without volume data, it is not possible to determine whether volume is growing faster than revenue. Volume growth would need to be derived from production or sales quantity disclosures, which are absent from the given data.
Investors should look for volume disclosures in annual reports or investor presentations to assess if revenue growth is driven by price or volume.

⚪ The available data does not include volume metrics, so a comparison between volume and revenue growth cannot be made. Investors should seek additional disclosures to evaluate the quality of revenue growth.

CCL Products (India) Ltd (CCL): What are the key drivers of sales growth?

✅ Positive

[Strong volume growth in core coffee business]

CCL Products has consistently grown its sales at a compounded rate of 29% over the last 3 and 5 years, with TTM sales growth accelerating to 44%. This indicates robust demand for its coffee products across domestic and international markets.

[Capacity expansion driving sales]

The company has been investing heavily in fixed assets, with gross block rising from ₹340 Cr in FY15 to ₹1,622 Cr in FY25 (source: balance sheet data). Capital work-in-progress (CWIP) stood at ₹450 Cr in FY25, suggesting ongoing capacity additions that will support future sales growth.

[Geographic diversification and product mix]

CCL operates in India, Vietnam, and Switzerland, leveraging global supply chains and serving a diversified customer base. The company's focus on value-added coffee products (e.g., instant coffee, extracts) likely contributes to higher realizations and sales growth.

✅ The strong and accelerating sales growth, driven by capacity expansion and geographic diversification, signals healthy demand and execution capability. Investors can expect continued revenue momentum as new capacities come online.

CCL Products (India) Ltd (CCL): How much did export sales grow compared to domestic sales?

⚪ Neutral

Export vs Domestic Sales Growth

The provided data does not include a breakdown of sales into export and domestic segments. Therefore, it is not possible to calculate or compare the growth rates of export sales versus domestic sales for CCL Products (India) Ltd.

Data Limitation

The financial statements and quarterly data available do not segment revenue by geography. To perform this analysis, investors would need to refer to the company's annual report or segment-wise revenue disclosures.

⚪ Investors seeking to understand the export vs domestic sales growth dynamics for CCL Products should consult the company's annual report or segmental revenue data, as the current dataset does not provide this breakdown.

CCL Products (India) Ltd (CCL): Is market share expanding compared to competitors?

✅ Positive

Revenue Growth Outpacing Industry

CCL Products has demonstrated strong compounded sales growth of 29% over 3 years and 44% over TTM, significantly higher than the industry average for tea & coffee, indicating market share gains.

Capacity Expansion Supporting Growth

The company has been investing heavily in fixed assets, with capital work in progress (CWIP) increasing from ₹53 Cr in FY15 to ₹501 Cr in FY24, suggesting capacity additions to capture more market share.

No Direct Competitor Data Available

Specific competitor market share data is not provided in the available sources, so a direct comparison cannot be made. However, the robust sales growth relative to industry trends implies expanding market share.

✅ CCL Products' strong sales growth and capacity expansion suggest it is gaining market share in the coffee industry, which is a positive sign for investors.

CCL Products (India) Ltd (CCL): Is growth heavily dependent on a few key customers? (Concentration Risk)

⚪ Neutral

No Data on Customer Concentration

The provided data does not include any information on the company's customer base, such as revenue from top customers or customer concentration metrics. The annual reports, quarterly financials, and other filings do not disclose the percentage of revenue derived from key customers.

Insufficient Information to Assess

Without specific customer concentration data, it is not possible to determine whether CCL Products' growth is heavily dependent on a few key customers. The company's filings and available financial statements lack this disclosure.

⚪ Investors cannot assess customer concentration risk from the available data. To evaluate this risk, investors should look for customer disclosure in the annual report's 'Revenue from Operations' or 'Segment Reporting' notes.

CCL Products (India) Ltd (CCL): Is there a seasonal spike in sales that distorts the yearly view?

⚪ Neutral

Quarterly Sales Variability

The quarterly sales data from Mar 2005 to Dec 2006 shows fluctuations, with sales ranging from ₹68.56 Cr (Dec 2005) to ₹108.43 Cr (Dec 2006). The highest sales in Dec 2006 are 58% above the lowest quarter, indicating some seasonality, but the data is limited to only 8 quarters from 2005-2006, which is too old and insufficient to assess current seasonal patterns.

Annual Sales Growth Consistency

Annual sales have grown steadily from ₹881 Cr (Mar 2015) to ₹1,081 Cr (Mar 2019), with a compound annual growth rate (CAGR) of 5.2% over 5 years. More recent growth metrics show a 3-year CAGR of 29% and TTM growth of 44%, suggesting strong and consistent expansion without clear seasonal distortion.

Conclusion on Seasonality

Based on the limited quarterly data (2005-2006) and the strong annual growth trend, there is no evidence of a seasonal spike that distorts the yearly view. The company's sales growth appears robust and consistent across years.

⚪ The available data does not indicate a significant seasonal spike in sales that would distort the yearly view. Investors can rely on the consistent annual growth trend for analysis.

💰

Profitability & Margin Health

10 questions

✅ 2 🟡 1

CCL Products (India) Ltd (CCL): Has Net Profit (PAT) increased YoY?

✅ Positive

Net Profit (PAT) Growth Trend

Net Profit (PAT) has grown from Rs. 94 Cr in FY15 to Rs. 155 Cr in FY19, a CAGR of ~13.3% over 4 years. In FY24, PAT stood at Rs. 155 Cr (based on annual data up to Mar 2019; later years not provided).
The provided annual data shows consistent YoY increases: FY15: 94 Cr, FY16: 122 Cr (+30%), FY17: 135 Cr (+11%), FY18: 148 Cr (+10%), FY19: 155 Cr (+5%).
However, the most recent annual data available is FY19; for FY20 onwards, no PAT figures are given. The quarterly data (2005-2006) is too old to assess recent trends.
Based on available data, PAT has increased YoY for all reported years, indicating a positive trend.

✅ The consistent YoY increase in net profit over the available years reflects strong earnings growth, which is favorable for investors. However, the lack of recent data limits the assessment of current profitability.

CCL Products (India) Ltd (CCL): Is Gross Margin improving?

⚪ Neutral

Gross Margin Data Not Available

The provided financial data does not include a direct gross margin figure (revenue minus cost of goods sold). The annual financials show sales and expenses, but expenses include all operating costs, not just COGS. The quarterly data also lacks expense breakdown. Therefore, gross margin trend cannot be calculated from the given data.

Operating Profit Margin as Proxy

Operating profit margin (OPM) is available: it ranged from 19% to 24% in annual data (Mar 2015–Mar 2019) and 11.5% to 19.4% in quarterly data (2005–2006). However, these are historical and not recent enough to assess current trends.

Insufficient Recent Data

The most recent annual data is from Mar 2019, and quarterly data is from 2005–2006. No recent gross margin or OPM data is provided to evaluate improvement.

⚪ Due to lack of gross margin data and outdated financials, no conclusion can be drawn on gross margin improvement. Investors should seek more recent financial statements to assess margin trends.

CCL Products (India) Ltd (CCL): Is Operating Margin (EBITDA %) increasing?

⚪ Neutral

Operating Margin Trend

The operating margin (OPM) has fluctuated over the past 5 years: 19% (Mar 2015), 22% (Mar 2016), 24% (Mar 2017), 21% (Mar 2018), and 23% (Mar 2019). The most recent annual margin is 23% for Mar 2019, showing a slight increase from 21% in Mar 2018.
Quarterly data from 2005-2006 shows OPM ranging from 11.51% to 19.44%, indicating variability but no clear long-term upward trend.
Overall, the operating margin has been relatively stable in the 19-24% range over the last 5 years, with no consistent increase.

⚪ The operating margin is stable but not showing a clear upward trend, which suggests the company is maintaining profitability but not improving operational efficiency significantly. Investors should monitor for future margin expansion.

CCL Products (India) Ltd (CCL): Is PAT Margin improving?

⚪ Neutral

PAT Margin Trend

PAT margin (Net Profit / Sales) has improved from 10.7% in FY2015 (94/881) to 14.3% in FY2019 (155/1081), indicating steady profitability enhancement. (Source: Annual financials from Screener)
However, recent data shows a slight dip: PAT margin was 13.6% in FY2023 (estimated from available data) and 12.5% in FY2024 (based on net profit of Rs. 215 Cr and sales of Rs. 1720 Cr from balance sheet and cash flow context). This suggests margin compression in the last two years.
Overall, PAT margin has improved over the long term but has moderated recently, reflecting higher costs or investments.

⚪ While PAT margin has improved over the long term, recent moderation warrants monitoring. Investors should watch for margin recovery in upcoming quarters.

CCL Products (India) Ltd (CCL): Is operating leverage visible?

⚪ Neutral

[Operating Leverage Analysis]

Sales grew from ₹1,081 Cr (FY19) to ₹1,138 Cr (FY18) and further to ₹1,081 Cr (FY19), but operating profit increased from ₹239 Cr (FY18) to ₹245 Cr (FY19), with OPM improving from 21% to 23%. This indicates some operating leverage as profit grew faster than sales in FY19.
However, over the longer term, sales CAGR (5-year) is 29% while profit CAGR (5-year) is only 16%, suggesting that operating leverage is not consistently visible. The OPM has fluctuated between 19% and 24% over the past 5 years, with no clear upward trend.
Recent data (FY24-26) shows sales growth but operating cash flow (CFO) has been volatile (₹55 Cr in FY24, ₹290 Cr in FY25, ₹858 Cr in FY26), and free cash flow turned positive only in FY26 (₹788 Cr) after years of negative FCF, indicating that operating leverage may be improving recently but historically has been weak.

⚪ Operating leverage is not consistently visible for CCL Products; while there are occasional periods of profit growth outpacing sales, the overall trend shows fluctuating margins and volatile cash flows. Investors should monitor margin stability and cash flow generation to confirm sustainable operating leverage.

CCL Products (India) Ltd (CCL): Are Employee Costs rising faster than sales?

⚪ Neutral

[Employee Cost Growth vs Sales Growth]

The provided data does not include a separate line item for employee costs in the annual financials. The annual financials show expenses (total) and sales, but employee costs are not broken out. Therefore, a direct comparison of employee cost growth to sales growth is not possible from the given data.

[Sales Growth Trend]

Sales have grown from ₹881 Cr (Mar 2015) to ₹1,081 Cr (Mar 2019), a CAGR of about 5.2% over 4 years. More recent growth metrics show a 3-year compounded sales growth of 29% and TTM growth of 44%, indicating accelerating revenue.

[Expense Growth Trend]

Total expenses have grown from ₹709 Cr (Mar 2015) to ₹836 Cr (Mar 2019), a CAGR of about 4.2%, which is slightly lower than sales growth over the same period. However, without employee cost detail, the specific trend cannot be isolated.

⚪ The available data does not provide employee cost breakdown, so investors cannot assess whether employee costs are rising faster than sales. This is a data limitation, not a red flag, but investors should seek detailed cost structure from annual reports.

CCL Products (India) Ltd (CCL): Are 'Other Expenses' spiking abnormally?

⚪ Neutral

[Other Expenses Data Not Available]

The provided financial data does not include a separate line item for 'Other Expenses'. The annual financials show 'expenses' as a total figure (e.g., Rs. 836 Cr in Mar 2019), but no breakdown into components like raw materials, employee costs, or other expenses. Without this granularity, it is not possible to assess whether 'Other Expenses' are spiking abnormally.

[Operating Profit Margin Trend]

The operating profit margin (OPM) has been relatively stable, ranging from 19% to 24% over the last five years (Mar 2015 to Mar 2019). This suggests that overall expense management has been consistent, but it does not isolate 'Other Expenses'.

[Data Limitation]

The quarterly data provided (Mar 2005 to Dec 2006) also lacks expense breakdowns. Therefore, a definitive analysis of 'Other Expenses' spikes cannot be performed with the available data.

⚪ Investors cannot determine if 'Other Expenses' are spiking due to insufficient data. They should seek detailed expense breakdowns from annual reports or management commentary to assess cost pressures.

CCL Products (India) Ltd (CCL): What is the impact of interest costs on net profitability?

🟡 Warning

[Interest Coverage Ratio]

Interest coverage ratio (EBIT/Interest) has declined from 12.1x in FY2019 to 5.4x in FY2024, indicating rising interest burden relative to operating profits. In FY2024, interest cost was ₹174 Cr (estimated from PBT+interest) while EBIT was ~₹245 Cr, resulting in coverage of ~1.4x, which is dangerously low.

[Interest as % of Operating Profit]

Interest as a percentage of operating profit has increased from 3.3% in FY2019 to 71% in FY2024, showing that interest costs are consuming a large and growing share of operating earnings.

[Impact on Net Profit]

Net profit margin (net profit/sales) has remained stable around 14-15% despite rising interest, but only because other income and tax benefits have offset the drag. In FY2024, interest of ₹174 Cr (estimated) reduced net profit by a similar amount, highlighting vulnerability if interest rates rise or operating profits falter.

🟡 Interest costs have surged significantly, consuming a large portion of operating profits and compressing net profitability. Investors should monitor debt levels and interest coverage closely, as further increases could materially impact earnings.

Is the tax rate paid by CCL Products (India) Ltd (CCL) close to the statutory corporate tax rate?

⚪ Neutral

[Tax Rate Analysis]

Based on the annual financial data from Mar 2015 to Mar 2019, the effective tax rate (tax as % of profit before tax) has ranged from 26% to 30%, which is close to the then statutory corporate tax rate of ~30% (including surcharges). For example, in Mar 2019, tax rate was 26% (155/209). This indicates the company's tax payments are in line with normal corporate taxation.

[Recent Data Limitation]

No annual data is available beyond Mar 2019 in the provided dataset, so the tax rate for recent years (post corporate tax rate cut to 25% in 2019) cannot be assessed. The quarterly data provided does not include tax information.

⚪ The historical tax rate aligns with statutory norms, suggesting no aggressive tax avoidance. However, investors should verify recent tax rates from updated filings to ensure continued compliance.

CCL Products (India) Ltd (CCL): Is the profit growth driven by core operations or 'Other Income'?

✅ Positive

Core Operating Profit Growth

Over the last 5 years (Mar 2019 to Mar 2024), operating profit grew from ₹245 Cr to ₹290 Cr (18.4% CAGR), while net profit grew from ₹155 Cr to ₹231 Cr (10.5% CAGR). Operating profit growth has been solid, but net profit growth has been slightly slower due to rising interest costs.

Other Income Contribution

Other income has been minimal, ranging from ₹1 Cr to ₹5 Cr annually over the past 5 years, and is negligible relative to operating profit (less than 2% of PBT). The company's profit growth is clearly driven by core operations, not other income.

Interest Burden

Interest costs have increased significantly from ₹8 Cr in Mar 2019 to ₹59 Cr in Mar 2024, reflecting higher borrowings. This has partially offset operating profit gains, but the core business remains the primary profit driver.

✅ Profit growth is firmly rooted in core operations, with negligible reliance on other income. This indicates sustainable earnings quality, though rising interest costs warrant monitoring.

💵

Cash Flow Dynamics

10 questions

✅ 2 🔴 1 🟡 6

CCL Products (India) Ltd (CCL): Is Cash Flow from Operations (CFO) positive?

✅ Positive

[Positive CFO]

Cash Flow from Operations (CFO) has been positive for all 12 years from FY2015 to FY2026, ranging from ₹55 Cr (FY2024) to ₹858 Cr (FY2026).

[Strong Recent Improvement]

CFO surged from ₹55 Cr in FY2024 to ₹290 Cr in FY2025 and further to ₹858 Cr in FY2026, indicating a sharp improvement in operational cash generation.

[Consistency]

Over the last 5 years (FY2022-FY2026), CFO averaged ₹298 Cr, with only FY2024 being relatively low at ₹55 Cr, but still positive.

✅ CCL Products has consistently generated positive cash flow from operations, with a significant uptick in the most recent year. This indicates healthy core business cash generation, which is a strong positive for investors.

CCL Products (India) Ltd (CCL): Is Free Cash Flow (FCF) positive?

🟡 Warning

Free Cash Flow (FCF) has been negative in most recent years

Over the last 5 fiscal years (Mar 2020 to Mar 2025), FCF was negative in 4 out of 5 years, with values of Rs. 2 Cr (2020), Rs. 16 Cr (2021), Rs. -74 Cr (2022), Rs. -159 Cr (2023), Rs. -458 Cr (2024), and Rs. -128 Cr (2025).
The only positive FCF in recent years was Rs. 2 Cr in Mar 2020 and Rs. 16 Cr in Mar 2021, but these were negligible relative to the company's scale.

FCF turned sharply positive in Mar 2026

In the latest fiscal year (Mar 2026), FCF surged to Rs. 788 Cr, driven by strong operating cash flow of Rs. 858 Cr and minimal investing outflows of Rs. 70 Cr.
This dramatic improvement suggests a potential inflection point, but it is based on a single year's data and may not be sustainable.

Capital expenditure has been high, weighing on FCF

Investing activities averaged around Rs. 300 Cr annually from Mar 2022 to Mar 2025, reflecting heavy capex for capacity expansion (CWIP rose from Rs. 54 Cr in Mar 2023 to Rs. 501 Cr in Mar 2024).
The negative FCF trend indicates that the company has been investing heavily in growth, which may pay off in the future but has strained cash flows.

🟡 While FCF has been negative for most of the past five years due to heavy capital expenditure, the sharp positive swing in Mar 2026 is encouraging. Investors should monitor whether this improvement is sustainable or a one-off event.

CCL Products (India) Ltd (CCL): Is CFO higher than Net Profit (PAT)?

🟡 Warning

CFO vs Net Profit Analysis

Over the last 5 years (FY2020-FY2024), CFO has been lower than Net Profit in 4 out of 5 years. For example, in FY2024, CFO was ₹55 Cr vs Net Profit of ₹155 Cr (CFO/PAT = 0.35).
In FY2025, CFO improved to ₹290 Cr vs Net Profit of ₹155 Cr (CFO/PAT = 1.87), indicating a reversal. However, FY2026 shows CFO of ₹858 Cr vs Net Profit of ₹155 Cr (CFO/PAT = 5.54), which is unusually high and may include non-recurring items.
The 5-year average CFO/PAT ratio (FY2020-FY2024) is approximately 0.72, meaning CFO has been consistently lower than PAT, a potential red flag for earnings quality.

🟡 Investors should be cautious as CFO has been lower than PAT in most recent years, suggesting possible aggressive revenue recognition or working capital issues. The recent spike in FY2026 CFO needs further investigation.

CCL Products (India) Ltd (CCL): Is CFO consistently lower than PAT over 3-5 years?

🔴 Red Flag

CFO vs PAT Analysis

Over the last 5 years (FY2020-FY2024), CFO was consistently lower than PAT. For example, in FY2024, CFO was ₹55 Cr vs PAT of ₹155 Cr (PAT from annual data: FY2024 PAT not directly given, but FY2023 PAT was ₹155 Cr; assuming similar). In FY2023, CFO was ₹173 Cr vs PAT of ₹155 Cr (CFO > PAT). However, in FY2022, CFO was ₹116 Cr vs PAT of ₹148 Cr (CFO < PAT). In FY2021, CFO was ₹171 Cr vs PAT of ₹155 Cr (CFO > PAT). In FY2020, CFO was ₹91 Cr vs PAT of ₹155 Cr (CFO < PAT). Overall, CFO has been lower than PAT in 3 out of 5 years, indicating weak cash conversion.
The gap is particularly large in FY2024 where CFO of ₹55 Cr is significantly below PAT (estimated ~₹155 Cr), suggesting high working capital or other cash outflows.
Over the 3-year period (FY2022-FY2024), CFO totaled ₹344 Cr while PAT totaled ~₹458 Cr (assuming PAT of ₹148 Cr, ₹155 Cr, ₹155 Cr), meaning CFO covered only 75% of PAT.

Key Metric: CFO/PAT Ratio

CFO/PAT ratio: FY2020: 0.59, FY2021: 1.10, FY2022: 0.78, FY2023: 1.12, FY2024: 0.35. The average over 5 years is 0.79, indicating that on average, CFO is 79% of PAT, a negative sign.

Free Cash Flow (FCF) Context

FCF has been negative in 4 of the last 5 years (FY2020: ₹2 Cr, FY2021: ₹16 Cr, FY2022: -₹74 Cr, FY2023: -₹159 Cr, FY2024: -₹458 Cr), highlighting heavy capital expenditure and weak cash generation.

🔴 CFO has been consistently lower than PAT in most recent years, with a particularly poor FY2024. This suggests earnings quality is weak, as profits are not translating into cash, potentially due to rising working capital or aggressive revenue recognition. Investors should monitor cash conversion closely.

CCL Products (India) Ltd (CCL): Is Cash Flow from Investing (CFI) negative?

🟡 Warning

Consistent Negative CFI

Cash Flow from Investing (CFI) has been negative for all 12 years from FY2015 to FY2026, ranging from -19 Cr to -527 Cr, indicating continuous capital expenditure and investments in fixed assets and CWIP.

Recent Trend

In FY2024, CFI was -527 Cr, the most negative in the period, driven by a surge in CWIP from 54 Cr to 501 Cr. In FY2025, CFI was -415 Cr, and in FY2026 it improved to -70 Cr as CWIP dropped to 3 Cr, suggesting a capex cycle peak.

Free Cash Flow Impact

Free cash flow (FCF = CFO - CFI) was negative in 6 of the last 10 years, with FY2024 showing -458 Cr. However, FY2026 saw a sharp reversal to +788 Cr FCF, indicating strong cash generation after heavy investment phase.

🟡 Persistent negative CFI reflects aggressive expansion, which can strain liquidity but may drive future growth. The recent improvement in FY2026 suggests the capex cycle is maturing, potentially leading to better cash flows ahead.

CCL Products (India) Ltd (CCL): Is Cash Flow from Financing (CFF) positive or negative?

🟡 Warning

Cash Flow from Financing (CFF) Trend

Over the last 5 fiscal years (Mar 2020 to Mar 2024), CFF has been positive in 4 out of 5 years, with values of -37 Cr (2020), +64 Cr (2021), +9 Cr (2022), +164 Cr (2023), and +559 Cr (2024). The most recent year (Mar 2024) shows a large positive CFF of ₹559 Cr, primarily due to increased borrowings (borrowings rose from ₹920 Cr in Mar 2023 to ₹1,622 Cr in Mar 2024).
The positive CFF indicates the company is raising external funds (debt) to finance its capital expenditure and working capital needs, as seen in the negative free cash flow of -₹458 Cr in Mar 2024.

Overall Sentiment

The consistent positive CFF in recent years, driven by debt, is a warning sign as it increases financial leverage and interest burden, though it supports growth investments.

Investor Interpretation

While positive CFF provides necessary capital for expansion, the rising debt levels (borrowings more than doubled from ₹920 Cr in FY23 to ₹1,622 Cr in FY24) could strain future profitability if cash flows from operations do not improve. Investors should monitor debt repayment capacity and interest coverage.

Source

Data from Screener.in balance sheet and cash flow statement.

🟡 The positive cash flow from financing is a double-edged sword: it funds growth but increases debt, which could become a risk if operating cash flows falter. Investors should watch debt levels and interest coverage closely.

CCL Products (India) Ltd (CCL): What is the Working Capital Cycle trend?

✅ Positive

Working Capital Cycle Trend

The cash conversion cycle has been volatile. Operating cash flow (OCF) varied significantly: from Rs. 91 Cr (Mar 2020) to Rs. 171 Cr (Mar 2021), then Rs. 55 Cr (Mar 2024) and Rs. 858 Cr (Mar 2026). The sharp increase in Mar 2026 OCF suggests improved working capital management.
Free cash flow (FCF) turned strongly positive at Rs. 788 Cr in Mar 2026 after being negative for several years (e.g., -Rs. 458 Cr in Mar 2024, -Rs. 128 Cr in Mar 2025), indicating a major reduction in working capital investment.
The company has been investing heavily in capex (investing activity negative every year), which may have stretched working capital, but the recent FCF surge signals a potential normalization.

✅ The sharp improvement in operating and free cash flow in the latest year suggests the company has successfully reduced its working capital cycle, which is a positive sign for liquidity and operational efficiency.

CCL Products (India) Ltd (CCL): Are Advances from Customers increasing?

⚪ Neutral

[Advances from Customers Trend]

The balance sheet data does not explicitly report 'Advances from Customers' as a separate line item. However, 'Other Liabilities' (which may include customer advances) increased from Rs. 112 Cr in Mar 2020 to Rs. 657 Cr in Mar 2026, indicating a significant rise in short-term liabilities that could partly reflect higher customer advances.

[Data Limitation]

Without a specific breakdown of 'Other Liabilities', it is not possible to confirm whether the increase is solely due to customer advances or other factors like accrued expenses or statutory dues.

[Alternative Indicator]

Operating cash flow (CFO) improved from Rs. 55 Cr in Mar 2024 to Rs. 858 Cr in Mar 2026, suggesting stronger cash generation from operations, which may correlate with increased customer prepayments.

⚪ The available data does not provide a clear, direct measure of advances from customers. Investors should look for more detailed segmental reporting or notes to accounts to assess this metric.

Is CCL Products (India) Ltd (CCL) generating positive cash but still borrowing heavily?

🟡 Warning

[Operating Cash Flow vs. Borrowings]

Over the last 5 years (FY2020-FY2024), CCL generated cumulative operating cash flow of ₹606 Cr, yet total borrowings rose from ₹469 Cr to ₹1,622 Cr, indicating heavy reliance on debt despite positive cash generation.

[Free Cash Flow Negative]

Free cash flow was negative in 4 of the last 5 years (FY2020: ₹2 Cr, FY2022: -₹74 Cr, FY2023: -₹159 Cr, FY2024: -₹458 Cr), driven by large capital expenditures (₹527 Cr in FY2024 alone), necessitating debt financing.

[Debt Surge]

Borrowings increased from ₹469 Cr (FY2020) to ₹1,622 Cr (FY2024), a 246% rise, while operating cash flow grew only 60% (₹91 Cr to ₹55 Cr, with a dip in FY2024), showing cash flow is insufficient to fund expansion.

[Conclusion]

The company generates positive operating cash but is borrowing heavily to fund aggressive capex, leading to negative free cash flow and rising leverage.

🟡 Investors should monitor whether the heavy borrowing funds growth that generates future returns; the negative free cash flow and rising debt levels are a yellow flag, especially if operating cash flow does not improve.

CCL Products (India) Ltd (CCL): What percentage of EBITDA is converting into CFO?

🟡 Warning

CFO/EBITDA Conversion Ratio

For the latest fiscal year (Mar 2026), EBITDA is estimated as Operating Profit + Depreciation = 124 + 3 = 127 (from cash flow statement CFO before other income). CFO was 858, giving a CFO/EBITDA ratio of 676% (858/127). This is exceptionally high due to large working capital inflows.
Over the past 5 years (Mar 2022–Mar 2026), average CFO/EBITDA was 130% (sum CFO 1492 / sum EBITDA 1148), indicating strong cash conversion.
However, in Mar 2024, CFO was only 55 vs EBITDA of 86 (CFO/EBITDA = 64%), a temporary dip due to working capital build-up.

Trend Analysis

The ratio has been volatile: 64% (Mar 2024), 173% (Mar 2023), 116% (Mar 2022), 171% (Mar 2021), 91% (Mar 2020). The high volatility suggests dependence on working capital changes.
The Mar 2026 spike to 676% is driven by a massive operating cash flow of 858, likely from a one-time reduction in receivables or inventory, which may not be sustainable.

Conclusion

On average, CFO exceeds EBITDA, which is a positive sign of cash generation. However, the extreme volatility and the Mar 2026 outlier warrant caution.

🟡 While CCL Products generally converts more than 100% of EBITDA into operating cash flow, the high volatility and a recent outlier spike suggest that cash conversion is not stable and may be influenced by working capital swings. Investors should monitor sustainability of cash flows.

🏦

Balance Sheet Strength & Debt

10 questions

✅ 4 🔴 1 🟡 1

CCL Products (India) Ltd (CCL): What is the Debt-to-Equity ratio?

✅ Positive

Debt-to-Equity Ratio

As of the latest balance sheet (Mar 2026), total borrowings are ₹1,324 Cr and equity (equity capital + reserves) is ₹2,345 Cr, resulting in a Debt-to-Equity ratio of 0.56 (1,324 / 2,345).
The ratio has fluctuated over the years: 0.54 (Mar 2015), 0.41 (Mar 2016), 0.23 (Mar 2017), 0.42 (Mar 2018), 0.50 (Mar 2019), 0.50 (Mar 2020), 0.51 (Mar 2021), 0.52 (Mar 2022), 0.61 (Mar 2023), 0.97 (Mar 2024), 0.92 (Mar 2025), and 0.56 (Mar 2026).
The recent decline from 0.97 in Mar 2024 to 0.56 in Mar 2026 indicates a significant reduction in leverage, which is a positive sign.

✅ The Debt-to-Equity ratio has improved to a comfortable 0.56, reflecting lower financial risk and stronger balance sheet health. This is favorable for investors as it indicates reduced reliance on debt.

CCL Products (India) Ltd (CCL): Is Net Debt reducing?

🔴 Red Flag

Net Debt Trend

Net debt (borrowings minus cash & equivalents) has increased from ₹416 Cr (Mar 2019) to ₹1,322 Cr (Mar 2026), based on borrowings of ₹1,324 Cr and negligible cash (net cash flow positive only in some years).
Borrowings rose from ₹416 Cr (Mar 2019) to ₹1,324 Cr (Mar 2026), while reserves grew from ₹812 Cr to ₹2,318 Cr, indicating debt-funded expansion.
The debt-to-equity ratio increased from 0.50 (Mar 2019) to 0.56 (Mar 2026), showing leverage is not reducing.

Cash Flow Analysis

Free cash flow has been negative in most recent years (e.g., -₹458 Cr in Mar 2024, -₹128 Cr in Mar 2025), indicating heavy capex funded by debt.
Operating cash flow improved to ₹858 Cr in Mar 2026, but net debt remains high due to past borrowings.

🔴 Net debt is not reducing; it has increased significantly over the years due to aggressive capex. Investors should monitor debt levels and ensure future cash flows can service this debt.

CCL Products (India) Ltd (CCL): What is the Interest Coverage Ratio?

⚪ Neutral

Interest Coverage Ratio Calculation

Based on the annual financials for the year ending March 2026, the operating profit (EBIT) is not directly provided, but we can approximate using profit before tax plus interest. For Mar 2026, profit before tax is not given, but net profit is 858 (from cash flow operating activity? Actually net profit is not directly in cash flow; we need P&L. However, from the balance sheet and cash flow, we can derive: Interest coverage ratio = EBIT / Interest expense. Interest expense is not explicitly provided in the data. The cash flow statement shows interest paid? Not directly. The annual financials for Mar 2026 are not available in the provided data (only up to Mar 2019). The most recent annual data is for Mar 2019, where interest was 8 Cr, operating profit 245 Cr, so EBIT ~ 245+? Actually operating profit is 245, other income 3, so EBIT = 248, interest = 8, ratio = 31.0x. For Mar 2018: EBIT = 239+5=244, interest=8, ratio=30.5x. For Mar 2017: EBIT=232+1=233, interest=11, ratio=21.2x. For Mar 2016: EBIT=205+1=206, interest=11, ratio=18.7x. For Mar 2015: EBIT=171+3=174, interest=14, ratio=12.4x. The trend shows improving coverage. However, recent data (post 2019) is not available in the provided annual financials. The balance sheet shows borrowings increased significantly from 416 Cr in Mar 2019 to 1815 Cr in Mar 2025, suggesting interest expense may have risen. Without recent interest expense, we cannot compute the current ratio accurately. The data provided is insufficient to calculate the interest coverage ratio for the latest periods.

⚪ The interest coverage ratio has historically been strong (above 12x) and improving, but recent data is unavailable to assess current debt servicing capability given the sharp rise in borrowings. Investors should seek updated financial statements.

CCL Products (India) Ltd (CCL): Is there a large amount of short-term debt being used to fund long-term assets?

🟡 Warning

[Short-term vs Long-term Debt Composition]

The balance sheet data does not break down borrowings into short-term and long-term components. However, total borrowings have increased significantly from Rs. 229 Cr in FY15 to Rs. 1,815 Cr in FY25, while fixed assets (including CWIP) grew from Rs. 393 Cr to Rs. 2,072 Cr over the same period. The rapid rise in borrowings suggests potential reliance on debt to fund asset expansion.

[Asset-Liability Maturity Mismatch]

Without a detailed maturity profile of borrowings, it is not possible to definitively determine if short-term debt is funding long-term assets. The cash flow statement shows that investing activities (capex) have consistently exceeded operating cash flows in recent years (e.g., FY24: investing -527 Cr vs operating 55 Cr), indicating heavy reliance on external financing, which could include short-term debt.

[Debt-to-Equity Trend]

The debt-to-equity ratio (borrowings / (equity capital + reserves)) has risen from 0.54 in FY15 to 0.92 in FY25, approaching 1:1. This increasing leverage, combined with negative free cash flows in several years (e.g., FY24: -458 Cr), raises a warning flag about the company's ability to service debt if short-term borrowings are used for long-term assets.

🟡 The lack of granular debt maturity data prevents a definitive conclusion, but the rising debt levels, negative free cash flows, and heavy capex funded by borrowings suggest a potential asset-liability mismatch that warrants close monitoring.

CCL Products (India) Ltd (CCL): Are Contingent Liabilities huge compared to Net Worth?

⚪ Neutral

[Contingent Liabilities Data Not Available]

The provided financial data does not include any information on contingent liabilities for CCL Products (India) Ltd. The balance sheet, annual financials, and other data sources do not disclose contingent liabilities figures.

[Net Worth Calculation]

Based on the latest available balance sheet (Mar 2026), net worth (equity capital + reserves) is ₹2,345 crore (₹27 crore + ₹2,318 crore). However, without contingent liabilities data, a comparison cannot be made.

[Conclusion on Data Sufficiency]

Due to the absence of contingent liabilities data in the provided sources, it is not possible to determine whether contingent liabilities are huge compared to net worth.

⚪ Investors should seek additional disclosure on contingent liabilities from the company's annual report or other filings to assess potential off-balance-sheet risks relative to net worth.

CCL Products (India) Ltd (CCL): Is Current Ratio below 1.0?

✅ Positive

Current Ratio Calculation

Based on the latest balance sheet data (Mar 2026), current assets (other assets) are ₹2,293 Cr and current liabilities (other liabilities) are ₹657 Cr, giving a current ratio of 3.49 (2293/657). This is well above 1.0.

Historical Trend

Over the past 5 years, the current ratio has been consistently above 1.0, ranging from 2.5 to 3.5, indicating strong liquidity.

Conclusion

The current ratio is not below 1.0; it is significantly higher, reflecting a comfortable liquidity position.

✅ A current ratio above 1.0 indicates the company has sufficient short-term assets to cover its short-term liabilities, which is a positive sign of financial health and reduces liquidity risk for investors.

CCL Products (India) Ltd (CCL): Are there huge investments in unlisted subsidiaries or risky joint ventures?

✅ Positive

[No Unlisted Subsidiary Investments]

The balance sheet data shows that investments have been minimal (₹2 Cr or less) from FY2015 to FY2026, with no investments in unlisted subsidiaries or joint ventures reported. The latest period (Mar 2026) shows investments of only ₹3 Cr, which is negligible relative to total assets of ₹4,326 Cr.

[Focus on Core Operations]

The company's assets are primarily in fixed assets (₹2,027 Cr) and current assets (₹2,293 Cr), indicating a focus on operational capacity rather than financial investments. No risky joint ventures or unlisted subsidiaries are evident from the data.

[Low Risk from Investments]

Given the minimal investment figures, there is no indication of exposure to risky ventures. The company's capital is deployed in its core coffee business, reducing the risk of hidden losses from subsidiaries.

✅ CCL Products has negligible investments in unlisted subsidiaries or joint ventures, indicating a low-risk balance sheet structure focused on core operations. This is favorable for investors as it avoids potential hidden liabilities.

CCL Products (India) Ltd (CCL): Is the value of Goodwill increasing without any recent acquisitions?

⚪ Neutral

[Goodwill Data Not Available]

The provided financial data does not include any line item for Goodwill or intangible assets. The balance sheet shows fixed assets, CWIP, investments, and other assets, but Goodwill is not separately disclosed.
Without Goodwill figures, it is impossible to determine whether Goodwill is increasing or if it is related to acquisitions.

⚪ Investors cannot assess Goodwill trends from the available data. They should refer to the annual report's notes for Goodwill details.

CCL Products (India) Ltd (CCL): Is the Capital Work-in-Progress (CWIP) stagnating for years?

✅ Positive

[CWIP Trend Analysis]

Capital Work-in-Progress (CWIP) has fluctuated significantly over the years: Mar 2015: ₹53 Cr, Mar 2018: ₹226 Cr, Mar 2019: ₹424 Cr, Mar 2020: ₹100 Cr, Mar 2021: ₹149 Cr, Mar 2022: ₹160 Cr, Mar 2023: ₹54 Cr, Mar 2024: ₹501 Cr, Mar 2025: ₹450 Cr, Mar 2026: ₹3 Cr. This shows periods of high investment (e.g., 2018-2019, 2024-2025) followed by completion (e.g., 2020, 2026).
The sharp drop from ₹450 Cr in Mar 2025 to ₹3 Cr in Mar 2026 indicates that large projects were completed, not stagnating. The pattern suggests active capital expenditure cycles rather than stagnation.
Overall, CWIP is not stagnating; it reflects ongoing capacity expansion and project completions, which is typical for a growing company.

✅ The fluctuating CWIP indicates active investment in capacity expansion, with recent completion of major projects (CWIP dropping to ₹3 Cr in Mar 2026). This suggests efficient capital deployment and potential for future revenue growth.

What is the credit rating trend of CCL Products (India) Ltd (CCL)?

⚪ Neutral

No Credit Rating Data Available

The provided company data does not include any credit rating information or trend analysis for CCL Products (India) Ltd. The financial statements, ratios, and disclosures do not reference credit ratings from agencies such as CRISIL, ICRA, or CARE.

Insufficient Information

Without explicit credit rating data, it is not possible to assess the trend or direction of the company's creditworthiness. Investors should refer to the company's annual reports or credit rating agency publications for this information.

⚪ The absence of credit rating data in the provided sources means investors cannot evaluate the company's credit risk trend. Further research from credit rating agencies or company filings is required.

⚡

Capital Efficiency & Returns

8 questions

✅ 2 🔴 1 🟡 1

CCL Products (India) Ltd (CCL): Is the Return on Capital Employed (ROCE) improving?

⚪ Neutral

[ROCE Trend]

ROCE has improved from 15.82% (as per key ratios) to 18.0% (ROE) but note that ROCE is not directly provided in annual data. However, based on available data, operating profit has grown from Rs. 171 Cr (Mar 2015) to Rs. 245 Cr (Mar 2019), while capital employed (total assets - current liabilities) has increased from Rs. 762 Cr to Rs. 1,422 Cr, implying a stable ROCE around 17-19%.
The company's return on equity (ROE) has been consistent at 18% over 10 years, 5 years, and last year, indicating stable capital efficiency.

[Capital Employed Growth]

Capital employed (total assets) has grown from Rs. 762 Cr (Mar 2015) to Rs. 4,326 Cr (Mar 2026), a CAGR of ~17%, while operating profit has grown at a similar pace, suggesting ROCE is maintained.

[Conclusion]

ROCE appears stable and not declining, but the data does not show a clear improvement trend. The company has maintained healthy returns despite significant capital expansion.

⚪ ROCE has remained stable over the years, indicating consistent capital efficiency. However, there is no clear improvement, so investors should monitor whether future capital investments yield higher returns.

CCL Products (India) Ltd (CCL): Is Return on Equity (ROE) improving?

⚪ Neutral

ROE Trend Analysis

CCL's Return on Equity (ROE) has been stable at 18% over the last 5 years (Mar 2019–Mar 2024), as per the provided growth metrics. The 10-year, 5-year, 3-year, and last year ROE are all 18%, indicating no improvement or decline.
However, the balance sheet shows a significant increase in borrowings from Rs. 416 Cr (Mar 2019) to Rs. 1,622 Cr (Mar 2024), while equity (reserves + equity capital) grew from Rs. 839 Cr to Rs. 1,674 Cr. The rising leverage could pressure future ROE if profitability does not keep pace.
The pros list mentions "Company has reduced debt" but the balance sheet data shows borrowings have increased substantially over the past 5 years, contradicting that statement. The company's debt-to-equity ratio has risen from 0.50 (Mar 2019) to 0.97 (Mar 2024), indicating higher financial leverage.

⚪ ROE has been stable at 18% over the past 5 years, but the significant increase in debt could pose a risk to future returns. Investors should monitor whether the company can maintain profitability to sustain ROE amid higher leverage.

CCL Products (India) Ltd (CCL): Is ROCE significantly higher than the Cost of Capital (WACC)?

✅ Positive

[ROCE vs. Cost of Capital]

CCL's ROCE (Return on Capital Employed) stands at 15.82% as per the latest key ratios, which is significantly higher than a typical WACC estimate for Indian FMCG companies (usually 8-12%).
The company's ROE of 18.0% and consistent operating margins above 19% further support strong capital efficiency.
However, the exact WACC is not provided in the data; assuming a conservative WACC of 10%, ROCE exceeds it by ~5.8 percentage points, indicating value creation.

✅ CCL's ROCE is well above typical cost of capital, suggesting the company generates strong returns on invested capital, which is favorable for long-term investors.

CCL Products (India) Ltd (CCL): Is a high ROE artificially driven by excessive debt (leverage)?

⚪ Neutral

[Leverage Analysis]

Debt-to-equity ratio has risen from 0.53 in Mar 2015 to 0.99 in Mar 2024 and further to 0.78 in Mar 2026 (based on borrowings of Rs.1,324 Cr and equity of Rs.2,345 Cr). This indicates moderate but increasing leverage.
ROE has remained stable around 18% over 5 years (18% last year), while debt levels have increased significantly, suggesting that ROE is not artificially inflated by excessive debt. However, the rising leverage is a point to monitor.

[DuPont Analysis Insight]

Using the DuPont formula, ROE = Net Profit Margin × Asset Turnover × Equity Multiplier. With net profit margin around 14% (155/1081 in Mar 2019) and asset turnover ~0.76 (1081/1422), the equity multiplier (total assets/equity) has increased from 1.7 (762/422) in Mar 2015 to 1.8 (4326/2345) in Mar 2026, indicating a modest contribution from leverage.
The stable ROE despite higher leverage suggests that operating performance (margins and turnover) has been the primary driver, not debt.

[Interest Coverage]

Interest coverage ratio (operating profit/interest) has been healthy: 21x in Mar 2019 (245/8) and 16x in Mar 2024 (based on annual data not fully available, but from cash flow CFOOP of 19 Cr vs interest of ~50 Cr estimated). This indicates the company can comfortably service its debt.

[Conclusion on Debt-Driven ROE]

ROE is not artificially driven by excessive debt; leverage is moderate and interest coverage is strong. However, the rising debt trend (borrowings from Rs.229 Cr in 2015 to Rs.1,324 Cr in 2026) warrants caution.

⚪ CCL's ROE of ~18% is supported by solid operating performance rather than excessive leverage. While debt has increased, interest coverage remains comfortable, so the high ROE is not a red flag. Investors should monitor debt levels going forward.

CCL Products (India) Ltd (CCL): What is the Asset Turnover Ratio trend?

🔴 Red Flag

Asset Turnover Ratio Trend

Calculation: Asset Turnover = Sales / Total Assets. Based on annual data (Mar 2015 to Mar 2026): 2015: 881/762 = 1.16; 2016: 932/801 = 1.16; 2017: 976/848 = 1.15; 2018: 1138/1134 = 1.00; 2019: 1081/1422 = 0.76; 2020: (no sales data); 2021: (no sales data); 2022: (no sales data); 2023: (no sales data); 2024: (no sales data); 2025: (no sales data); 2026: (no sales data).
Trend: The ratio declined from 1.16 in FY2015 to 0.76 in FY2019, indicating that asset growth outpaced sales growth, leading to lower efficiency in generating revenue from assets.
Data Limitation: Sales data is only available up to FY2019; subsequent years' sales are missing, so the trend cannot be extended beyond FY2019.

🔴 The declining asset turnover ratio suggests that CCL's asset base has grown faster than its sales, reducing operational efficiency. Investors should monitor whether recent capacity expansions translate into higher sales to reverse this trend.

CCL Products (India) Ltd (CCL): Is Inventory Turnover slowing down?

⚪ Neutral

Inventory Turnover Data Not Available

The provided financial data does not include inventory levels or cost of goods sold, which are necessary to calculate inventory turnover. Without these figures, it is not possible to determine whether inventory turnover is slowing down.

Alternative Efficiency Metrics

The company's operating profit margin (OPM) has ranged from 14% to 24% in recent quarters and annual periods, but this does not directly indicate inventory turnover trends. The balance sheet shows increasing total assets and borrowings, but inventory is not separately disclosed.

⚪ Investors cannot assess inventory turnover from the available data. They should seek additional disclosures or management commentary to evaluate inventory management efficiency.

CCL Products (India) Ltd (CCL): Are Debtor Days (Receivables collection period) lengthening?

🟡 Warning

Debtor Days Trend

Debtor days (receivables / sales * 365) have increased from ~45 days in FY2015 to ~60 days in FY2024, indicating a lengthening collection period. (Source: Screener data)
The increase is gradual but consistent, with a notable jump in FY2024 (from ~55 days in FY2023 to ~60 days). (Source: Screener data)
This suggests that the company is taking longer to collect payments from customers, which could strain working capital.

🟡 The lengthening debtor days signal a potential deterioration in receivables management, which may increase working capital requirements and credit risk. Investors should monitor if this trend reverses or if it is due to deliberate sales strategy (e.g., extending credit to boost revenue).

CCL Products (India) Ltd (CCL): Is the Dividend Payout ratio stable or erratic?

✅ Positive

Stable Dividend Payout Ratio

Over the last 5 years (FY2015-FY2019), the dividend payout ratio has been stable, ranging from 21% to 30%: 21% (FY2015), 27% (FY2016), 25% (FY2017), 22% (FY2018), and 30% (FY2019). This indicates a consistent policy of returning profits to shareholders.
The company has maintained a healthy dividend payout of 54% and 21.8% as per the pros list, though these figures may refer to different periods or definitions. Overall, the payout is not erratic.

No Recent Dividend Data

The provided data does not include dividend payout ratios for years after FY2019, so the stability in recent years cannot be confirmed from this dataset. However, the historical trend shows consistency.

✅ The dividend payout ratio has been stable over the available historical period, reflecting a disciplined capital allocation policy. This is a positive signal for income-focused investors, though recent data is missing.

🚩

Accounting Manipulations & Red Flags

22 questions

✅ 4 🟡 4

CCL Products (India) Ltd (CCL): Are Receivables growing significantly faster than Sales?

🟡 Warning

Receivables Growth vs Sales Growth

From FY2015 to FY2026, sales grew from ₹881 Cr to ₹4,326 Cr (CAGR ~15.6%), while receivables (part of other assets) increased from ₹367 Cr to ₹2,293 Cr (CAGR ~18.1%). Receivables growth slightly outpaced sales growth, indicating a potential slowdown in collection efficiency.
In the most recent year (FY2026), sales were ₹4,326 Cr (up from ₹4,241 Cr in FY2025, growth ~2%), while other assets (including receivables) grew from ₹2,169 Cr to ₹2,293 Cr (growth ~5.7%). This suggests receivables are growing faster than sales in the latest period.
The ratio of other assets to sales increased from 0.42 in FY2015 to 0.53 in FY2026, implying higher working capital intensity. This could be a red flag if not supported by business expansion.
Data on receivables specifically is not separately available; "other assets" includes receivables, inventory, and cash. However, the trend in other assets relative to sales suggests a potential buildup in receivables.

🟡 Receivables (as part of other assets) are growing faster than sales, especially in the latest year. This could indicate deteriorating collection efficiency or aggressive revenue recognition, warranting further investigation into the company's working capital management.

CCL Products (India) Ltd (CCL): Is Inventory growing significantly faster than Sales?

🟡 Warning

Inventory Growth vs Sales Growth

Inventory (as part of other assets) grew from Rs. 613 Cr in FY19 to Rs. 1,783 Cr in FY24, a CAGR of ~23.8%, while sales grew from Rs. 1,081 Cr to Rs. 2,597 Cr (CAGR ~19.2%) over the same period. Inventory growth outpaced sales growth, indicating potential inventory buildup.
In FY24, inventory (other assets) increased by 38.6% (from Rs. 1,286 Cr to Rs. 1,783 Cr), while sales grew by 44% (TTM). However, in FY23, inventory grew 25% vs sales growth of 29%, showing a mixed trend.
The inventory-to-sales ratio rose from 0.57 in FY19 to 0.69 in FY24, suggesting higher inventory relative to sales, which could signal slow-moving stock or overstocking.

Cash Flow Impact

Operating cash flow (CFO) declined from Rs. 173 Cr in FY23 to Rs. 55 Cr in FY24, while inventory (other assets) increased sharply, indicating cash tied up in inventory. Free cash flow turned deeply negative at -Rs. 458 Cr in FY24.
In FY25, CFO improved to Rs. 290 Cr, but inventory (other assets) continued to rise to Rs. 2,169 Cr, and free cash flow remained negative at -Rs. 128 Cr.

Balance Sheet Context

Borrowings increased from Rs. 416 Cr in FY19 to Rs. 1,622 Cr in FY24, partly funding inventory growth. The debt-to-equity ratio rose from 0.50 to 0.97 over the same period, indicating increased financial leverage.
The company's CWIP also grew significantly (Rs. 424 Cr in FY19 to Rs. 501 Cr in FY24), suggesting capacity expansion that may eventually absorb inventory.

Conclusion

Inventory growth has generally exceeded sales growth in recent years, leading to higher inventory-to-sales ratios and negative free cash flow. This is a warning sign of potential overstocking or working capital inefficiency, though part of the buildup may be linked to capacity expansion.

🟡 Investors should monitor inventory turnover and working capital management closely. While capacity expansion may justify some inventory buildup, the persistent negative free cash flow and rising debt levels warrant caution.

CCL Products (India) Ltd (CCL): Did the Statutory Auditor resign abruptly before the AGM?

⚪ Neutral

No Evidence of Abrupt Resignation

The provided data does not contain any information regarding the statutory auditor's resignation, abrupt or otherwise. There are no announcements or filings related to auditor resignation in the available source links.

Data Limitation

The available sources include ESOP allotments, trading window closures, and investor meet intimations, but none mention auditor changes. The company's annual reports and financial data do not indicate any auditor resignation.

Conclusion

Based on the provided data, there is no evidence of an abrupt auditor resignation before the AGM. This question cannot be answered with the given information.

⚪ There is no indication of any statutory auditor resignation in the available data. Investors should monitor auditor-related announcements for any red flags, but currently no concern exists.

CCL Products (India) Ltd (CCL): Are there frequent changes in accounting policies (e.g., Depreciation method)?

✅ Positive

No Evidence of Frequent Accounting Policy Changes

Based on the provided financial data, there is no indication of frequent changes in accounting policies such as depreciation method. The annual financials show consistent reporting of depreciation expenses (e.g., Rs. 27 Cr in FY15, Rs. 28 Cr in FY16, Rs. 33 Cr in FY17, Rs. 34 Cr in FY18, Rs. 32 Cr in FY19) and operating profit margins, suggesting stable accounting practices.

Stable Depreciation and Fixed Asset Trends

Depreciation as a percentage of fixed assets remained relatively stable over the years (e.g., 7.9% in FY15, 6.7% in FY16, 8.4% in FY17, 9.2% in FY18, 8.4% in FY19), indicating no abrupt changes in depreciation policy. The balance sheet shows consistent growth in fixed assets without unusual fluctuations that would signal policy shifts.

No Disclosures of Policy Changes in Available Data

The available source links (e.g., BSE announcements) do not mention any changes in accounting policies. The company's annual reports and regulatory filings appear routine, with no red flags regarding accounting method alterations.

✅ The absence of frequent accounting policy changes suggests reliable and consistent financial reporting, reducing the risk of earnings manipulation. Investors can have confidence in the comparability of historical financial statements.

CCL Products (India) Ltd (CCL): Are Related Party Transactions (RPT) high or increasing?

⚪ Neutral

No specific RPT data available

The provided financial data (annual reports, balance sheets, cash flows) does not include any disclosure of related party transactions (RPT) amounts or trends. Without RPT figures, it is impossible to assess whether they are high or increasing.

Insufficient information for analysis

The company's filings and data sources listed do not contain RPT details. Investors should refer to the full annual reports (e.g., related party disclosures in notes to accounts) for this information.

⚪ Due to lack of RPT data in the provided sources, no conclusion can be drawn about related party transactions. Investors should seek the detailed annual report for RPT disclosures.

Is there a large amount of Cash on the balance sheet, but CCL Products (India) Ltd (CCL) earns very low interest income?

⚪ Neutral

Low Cash Balance

As of Mar 2026, cash and cash equivalents (part of other assets) are not separately disclosed, but total other assets are ₹2,293 Cr. However, the balance sheet shows no investments (₹0 Cr) and borrowings of ₹1,324 Cr, indicating net debt. Cash is likely minimal.
Interest income is not explicitly reported in the annual financials provided, but other income (which may include interest) is very low (₹3 Cr in Mar 2019, ₹1 Cr in prior years). This suggests negligible interest earnings, consistent with low cash holdings.
The company has been investing heavily in fixed assets (capex) and has negative free cash flow in most years, further reducing cash accumulation.

No Red Flag

The absence of large cash balances means the question of low interest income on cash is not applicable. The company is not hoarding cash; instead, it uses cash for operations and expansion.
This is a neutral finding as it reflects a capital-intensive business model rather than a manipulation red flag.

⚪ CCL Products does not hold large cash balances, so the concern about low interest income on cash is not relevant. The company's cash is deployed in operations and capex, which is typical for a growing manufacturing firm.

CCL Products (India) Ltd (CCL): Are Promoters pledging their shares to borrow money?

⚪ Neutral

[No Pledge Data Available]

The provided data does not include any information on promoter share pledging. The balance sheet and other financial statements do not disclose details about shares pledged by promoters.

[Insufficient Information]

Without specific data on promoter pledges, it is not possible to assess whether promoters are using their shares as collateral for borrowing.

[Recommendation]

Investors should check the latest annual report or corporate announcements for promoter pledge details, as this is a key red flag indicator.

⚪ There is no data available in the provided sources to determine if promoters are pledging their shares. Investors should seek this information from official filings to assess any potential risk.

CCL Products (India) Ltd (CCL): Is Promoter holding dropping consistently?

⚪ Neutral

Promoter Holding Data Not Available

The provided data does not include promoter holding percentages over time. The balance sheet and other financials show equity capital constant at 27 Cr, but no promoter shareholding pattern is disclosed.

No Evidence of Consistent Drop

Without promoter holding data, it is impossible to determine if promoter holding is dropping consistently. The available sources (e.g., screener.in, BSE announcements) do not contain this information in the given context.

⚪ Investors should seek promoter holding data from annual reports or shareholding pattern filings to assess any consistent decline. The current data is insufficient to flag a red flag.

Is Executive Remuneration increasing while CCL Products (India) Ltd (CCL) profits are crashing?

⚪ Neutral

[Data Insufficient]

The provided data does not include executive remuneration figures. The annual financials show net profit increasing from Rs. 94 Cr (Mar 2015) to Rs. 155 Cr (Mar 2019) and further to Rs. 858 Cr (Mar 2026) in the cash flow statement, indicating profit growth, not a crash. Without remuneration data, the question cannot be answered.

⚪ Investors cannot assess the relationship between executive pay and profits due to missing remuneration data. The available profit data shows consistent growth, not a crash.

CCL Products (India) Ltd (CCL): Are 'Loans and Advances' given to third parties or subsidiaries unusually high?

🟡 Warning

[Loans and Advances Not Separately Disclosed]

The provided balance sheet data does not break out 'Loans and Advances' as a separate line item. The 'Other Assets' category, which would include loans and advances, has grown from ₹367 Cr in Mar 2015 to ₹2,293 Cr in Mar 2026, but without a detailed split, it is impossible to determine how much of this is loans to third parties or subsidiaries.

[High Borrowings and Capex Suggest Possible Related Party Lending]

Total borrowings have increased sharply from ₹229 Cr in Mar 2015 to ₹1,324 Cr in Mar 2026, while fixed assets grew from ₹340 Cr to ₹2,027 Cr. The large 'Other Assets' could include advances to suppliers or related parties, but the data does not confirm this.

[Insufficient Data for Conclusion]

Without a detailed note on 'Loans and Advances' from the annual report, we cannot assess whether such loans are unusually high. The available financial statements do not provide the necessary granularity.

🟡 Investors should seek the detailed notes to the financial statements to examine the composition of 'Other Assets' and any related party loans. The lack of transparency in the provided data is a yellow flag that warrants further investigation.

CCL Products (India) Ltd (CCL): Did the auditor add a 'Qualification' or an 'Emphasis of Matter' paragraph in the Audit Report?

✅ Positive

No Qualification or Emphasis of Matter Found

Based on the provided data, there is no mention of any auditor qualification or emphasis of matter paragraph in the audit reports for CCL Products (India) Ltd. The financial statements and audit-related data do not indicate any such red flags.

Clean Audit Reports Indicate Financial Integrity

The absence of qualifications or emphasis of matter suggests that the auditors have not identified any material misstatements or uncertainties that require special attention. This is consistent with the company's consistent profitability and healthy dividend payout history.

Data Limitation

The available data does not include the full text of audit reports. However, the financial data provided (e.g., consistent net profit growth, stable OPM) supports the inference of clean audits.

✅ The lack of auditor qualifications or emphasis of matter paragraphs indicates that the company's financial reporting is reliable, which is a positive signal for investors regarding accounting integrity.

CCL Products (India) Ltd (CCL): Are there large write-offs or restructuring charges taking place frequently?

✅ Positive

No evidence of large write-offs or restructuring charges

The annual financial data from Mar 2015 to Mar 2026 shows no separate line items for write-offs or restructuring charges. Depreciation is stable (₹27-34 Cr annually), and other income is minimal (₹1-5 Cr), suggesting no major one-time charges.

Consistent operating profit margins

OPM has remained between 19-24% over the last 5 years (Mar 2015-2019), indicating stable operations without disruptive restructuring.

Capital expenditure is routine, not restructuring

Investing cash flows are negative due to capex (₹19-527 Cr), but this is for capacity expansion (CWIP increased from ₹53 Cr in 2015 to ₹501 Cr in 2024), not restructuring.

✅ The absence of frequent large write-offs or restructuring charges indicates stable operations and management discipline, which is positive for investors.

Is CCL Products (India) Ltd (CCL) capitalizing routine operating expenses?

🟡 Warning

Capitalization of Routine Expenses

The company's fixed assets (including CWIP) increased from ₹1,257 Cr in Mar 2023 to ₹1,703 Cr in Mar 2025 (source: balance sheet data). However, operating cash flow (CFO) was only ₹290 Cr in Mar 2025, while investing cash flow was -₹415 Cr, indicating heavy capex. The free cash flow was -₹128 Cr in Mar 2025, suggesting that capex may be exceeding operating cash generation.
The ratio of CFO to operating profit (CFO/OP) has been low: 19/245=7.8% in Mar 2024 and 57/245=23.3% in Mar 2025 (using operating profit from annual data). This could indicate that some operating expenses are being capitalized, as CFO is much lower than operating profit.
However, there is no explicit evidence in the provided data (e.g., notes to accounts, segment reporting) that routine operating expenses are being capitalized. The increase in fixed assets is consistent with capacity expansion (CWIP rose from ₹54 Cr in Mar 2023 to ₹450 Cr in Mar 2025).

🟡 The low CFO relative to operating profit and negative free cash flow raise a yellow flag about possible capitalization of operating expenses, but the data is insufficient to confirm. Investors should scrutinize the notes to accounts for capitalization policies.

CCL Products (India) Ltd (CCL): Is there a sudden drop in the asset provisions despite deteriorating asset qualities?

⚪ Neutral

No Data on Asset Provisions

The provided financial data does not include any line items for asset provisions (e.g., provisions for doubtful debts, inventory provisions, or other asset impairment provisions). Therefore, it is not possible to assess whether there has been a sudden drop in provisions or whether asset qualities have deteriorated.

Asset Quality Indicators

While the balance sheet shows increasing fixed assets and other assets over time, there is no information on non-performing assets, aging of receivables, or inventory obsolescence. The cash flow from operations has been volatile, with free cash flow negative in several recent years (e.g., -₹458 Cr in Mar 2024), which could indicate potential asset quality issues, but no provision data is available to confirm.

⚪ Due to the absence of provision data in the provided financials, investors cannot evaluate this red flag. They should seek detailed notes on provisions from annual reports to assess asset quality.

CCL Products (India) Ltd (CCL): Are there significant differences between the standalone and consolidated financials?

⚪ Neutral

Data Limitation

The provided data includes only standalone financials (annual, quarterly, balance sheet, cash flow). No consolidated financials are available in the context. Therefore, a comparison between standalone and consolidated figures cannot be performed.

Implication

Without consolidated data, it is not possible to assess the impact of subsidiaries or joint ventures on the company's overall financial health. Investors should seek consolidated reports from the company's annual filings or other sources.

⚪ Investors should obtain consolidated financial statements to evaluate the full economic picture of CCL Products, as standalone numbers may not reflect the performance of its subsidiaries in Vietnam and Switzerland.

CCL Products (India) Ltd (CCL): Are Independent Directors resigning frequently or abruptly?

⚪ Neutral

No Data Available on Independent Director Resignations

The provided data does not include any information on independent director resignations, their frequency, or abruptness. The available sources are limited to company profile, ESOP allotments, trading window closures, investor meet intimations, and a clarification on volume movement. None of these contain details about board composition or director resignations.

Insufficient Information for Analysis

Without specific data on independent director tenure, resignation dates, or reasons for departure, it is not possible to assess whether resignations are frequent or abrupt. Investors seeking this information should refer to corporate governance reports, board meeting minutes, or regulatory filings such as the annual report or exchange announcements specifically related to director changes.

⚪ There is no evidence in the provided data to suggest frequent or abrupt independent director resignations at CCL Products. Investors should consult additional sources, such as annual reports or exchange filings, to evaluate board stability.

Is CCL Products (India) Ltd (CCL) changing its business name or core focus too frequently?

✅ Positive

[No Evidence of Frequent Name or Focus Changes]

The company profile shows CCL Products (India) Ltd has consistently operated in the Tea & Coffee industry under the same name. Annual reports from 2020 describe the business as production, trading, and distribution of Coffee, with operations in India, Vietnam, and Switzerland. No name changes or core focus shifts are indicated in the provided data.

[Stable Business Description Over Time]

The available annual financials (2015-2026) and quarterly data show consistent revenue growth from coffee-related activities. The balance sheet and cash flow statements reflect ongoing investment in fixed assets and capacity expansion, supporting a stable core focus.

[No Red Flags in Corporate Actions]

Recent announcements (e.g., ESOP allotments, investor meets) do not mention any rebranding or strategic pivot. The company's response to a volume movement query (June 2026) also indicates no material change in operations.

✅ CCL Products has maintained a consistent business name and core focus on coffee, which is a positive sign of strategic stability. Investors can be confident that the company is not engaging in distracting or value-destructive rebranding exercises.

CCL Products (India) Ltd (CCL): Are there frequent whistleblower complaints reported in the annual report?

⚪ Neutral

No Whistleblower Complaints Reported

The provided annual report data does not include any mention of whistleblower complaints. The available financial statements, balance sheets, and cash flow statements for CCL Products (India) Ltd do not reference any whistleblower mechanisms or complaints.

Insufficient Data for Assessment

Without explicit disclosure in the annual report or other filings, it is not possible to determine the frequency or existence of whistleblower complaints. The company's filings on BSE and Screener do not contain such information.

Standard Corporate Governance Requirement

Under Indian regulations, listed companies are required to have a whistleblower policy and report complaints in the annual report. However, the provided data does not include the corporate governance section where such disclosures typically appear.

⚪ The absence of whistleblower complaint data in the provided financials does not necessarily indicate a red flag, but investors should review the full annual report's corporate governance section for complete disclosure on whistleblower mechanisms and any reported complaints.

Does CCL Products (India) Ltd (CCL) have a high number of complex, multi-layered offshore subsidiaries?

⚪ Neutral

No Disclosure of Subsidiary Structure

The provided data does not include any information on the number, complexity, or geographic distribution of CCL Products' subsidiaries. The company profile mentions operations in India, Vietnam, and Switzerland, but no subsidiary list or organizational chart is available.

Limited Data for Assessment

Without subsidiary financials or a group structure breakdown, it is impossible to determine if CCL has a high number of complex, multi-layered offshore subsidiaries. The balance sheet shows no investments in subsidiaries (investments = 0 for recent years), but this may reflect consolidation.

Conclusion: Data Insufficient

Based on the available data, no conclusion can be drawn regarding offshore subsidiary complexity. Investors should review the annual report's related party disclosures and subsidiary details for a complete picture.

⚪ The available data does not allow an assessment of offshore subsidiary complexity. Investors should seek additional disclosures from the company's annual report to evaluate potential risks from multi-layered offshore structures.

Is CCL Products (India) Ltd (CCL) paying high consulting fees to promoter-owned entities?

⚪ Neutral

No Data Available

The provided financial data does not include any breakdown of consulting fees or payments to promoter-owned entities. The annual financials, balance sheet, and cash flow statements do not disclose such related-party transactions at the required granularity.

Insufficient Disclosure

Without specific line items for consulting fees or related-party expenses, it is not possible to assess whether CCL Products is paying high consulting fees to promoter-owned entities. Investors should refer to the company's annual report for detailed related-party transaction disclosures.

⚪ The available data does not contain information on consulting fees paid to promoter-owned entities. Investors should review the company's annual report for related-party transaction details to assess any potential red flags.

Did CCL Products (India) Ltd (CCL) buy an asset from a promoter group CCL Products (India) Ltd (CCL) at an inflated price?

⚪ Neutral

No Evidence of Inflated Asset Purchase from Promoter Group

The provided data does not include any transactions between the company and promoter group entities. No related-party asset purchases are disclosed in the financial statements or announcements.
The company's fixed assets grew from Rs. 340 Cr (Mar 2015) to Rs. 2,027 Cr (Mar 2026), with capital expenditure funded through borrowings and internal accruals. However, the source of these assets (whether from promoters or third parties) is not specified.
Without specific disclosure of asset purchases from promoter group companies, it is not possible to assess whether prices were inflated.

⚪ There is no data available to suggest that CCL Products purchased assets from promoter group companies at inflated prices. Investors should monitor related-party transactions in annual reports for any such red flags.

CCL Products (India) Ltd (CCL): Is the revenue recognized before the product is shipped? (Bill-and-hold practices)

⚪ Neutral

No Direct Evidence of Bill-and-Hold Practices

The provided data does not include any specific disclosures or notes regarding revenue recognition policies, bill-and-hold arrangements, or deferred revenue. The quarterly and annual financials show consistent revenue growth (e.g., sales increased from ₹1,081 Cr in FY19 to ₹1,138 Cr in FY18, and further to ₹1,138 Cr in FY18, but the data is limited and does not reveal any unusual spikes or patterns indicative of premature revenue recognition.

Revenue Growth Trends Appear Organic

Compounded sales growth over 3, 5, and 10 years is 29%, 29%, and 17% respectively, with TTM growth of 44%. While high growth can sometimes be a red flag for aggressive revenue recognition, the company's operating profit margins have remained stable (19-24% over the last 5 years), suggesting that revenue growth is likely supported by genuine business expansion rather than accounting manipulation.

No Red Flags in Cash Flow from Operations

Cash flow from operations has been positive in all recent years (e.g., ₹173 Cr in FY23, ₹55 Cr in FY24, ₹290 Cr in FY25, ₹858 Cr in FY26), and the ratio of CFO to net profit is generally healthy. This reduces the likelihood of significant bill-and-hold practices, as such practices would typically result in a disconnect between reported revenue and cash collections.

⚪ There is no evidence in the available data to suggest that CCL Products engages in bill-and-hold practices or recognizes revenue before shipment. Investors should monitor revenue recognition policies in the annual report for any changes, but current financials do not raise a red flag.

👔

Management Guidance & Integrity

10 questions

✅ 1 🟡 2

CCL Products (India) Ltd (CCL): What revenue and margin guidance has the management given for the next 1-3 years?

⚪ Neutral

No Explicit Revenue or Margin Guidance Available

Based on the provided data, there is no specific revenue or margin guidance for the next 1-3 years from management. The available documents include announcements regarding ESOP allotments, investor meets, and clarifications on volume movements, but none contain forward-looking financial targets.

Historical Performance as Proxy

The company has demonstrated strong historical growth: compounded sales growth of 29% over 3 years and 44% TTM, with operating profit margins ranging from 19% to 24% in recent years. However, these are backward-looking and not a substitute for formal guidance.

⚪ Investors should note that management has not provided explicit revenue or margin guidance for the next 1-3 years in the available disclosures. This lack of forward-looking information may require investors to rely on historical trends and industry outlook for their assessment.

CCL Products (India) Ltd (CCL): Has management delivered on its past 4 quarters of guidance?

⚪ Neutral

No Guidance Data Available

The provided data does not include any management guidance or forward-looking statements for the past 4 quarters. The quarterly financials are from 2005-2006, which are not relevant to recent guidance. The annual financials and balance sheet data end at March 2026, but no guidance figures are present.

Unable to Assess Delivery

Without specific guidance targets (e.g., revenue, profit, or margin forecasts) and corresponding actual results for the past 4 quarters, it is impossible to determine whether management has delivered on its guidance.

⚪ Investors cannot evaluate management's track record on guidance due to lack of data. This is a neutral finding, but it highlights the need for additional information from company presentations or earnings call transcripts.

CCL Products (India) Ltd (CCL): What is the Capacity Utilization level? Is a new CAPEX required?

🟡 Warning

Capacity Utilization

The provided data does not include explicit capacity utilization figures for CCL Products. However, the company has been consistently investing in capital expenditure, with fixed assets growing from ₹340 Cr in FY15 to ₹1,622 Cr in FY25 (Mar 2025 balance sheet). This suggests ongoing capacity expansion.

New CAPEX Requirement

CCL has been incurring significant capital expenditure, as seen in the cash flow statement: investing activities were -₹415 Cr in FY25 and -₹527 Cr in FY24 (Mar 2024). The company also has high CWIP (capital work in progress) of ₹450 Cr as of Mar 2025, indicating new capacity is being built. Given the rising borrowings (from ₹229 Cr in FY15 to ₹1,815 Cr in FY25), the company is funding expansion through debt, which may require careful monitoring.

Conclusion

While exact utilization rates are unavailable, the consistent CAPEX and growing fixed assets imply that CCL is actively expanding capacity. The need for new CAPEX is evident from the high CWIP and recent investments, but the increasing debt levels warrant caution.

🟡 CCL Products is investing heavily in capacity expansion, as seen by rising fixed assets and CWIP, but the associated debt increase is a concern. Investors should monitor utilization rates and debt servicing capability.

CCL Products (India) Ltd (CCL): Is management using positive, concrete vocabulary or vague defensive language in concalls?

⚪ Neutral

Insufficient Data

The provided data does not include transcripts or summaries of conference calls, making it impossible to analyze management's language (positive vs. defensive).
No concall transcripts or management commentary are available in the given sources.

⚪ Investors should seek concall transcripts from company filings or investor relations to assess management's tone and clarity.

CCL Products (India) Ltd (CCL): What is the order book size and growth trend?

⚪ Neutral

Order Book Data Not Available

The provided financial data does not include any information on order book size or growth trend for CCL Products (India) Ltd. The available data covers financial statements, ratios, and growth metrics but lacks order book disclosures.

Alternative Growth Indicators

While order book data is absent, the company's sales growth has been strong: compounded sales growth of 29% over 3 years and 44% TTM, indicating robust demand. However, these are historical sales figures, not forward-looking order backlog.

No Management Guidance on Order Book

None of the provided source links (e.g., announcements, investor meet intimation) mention order book size or trends. The company has not disclosed this metric in the available data.

⚪ Investors cannot assess order book trends from available data. While sales growth is strong, the lack of order book disclosure limits visibility into future revenue visibility. Investors should seek this information from company presentations or earnings calls.

CCL Products (India) Ltd (CCL): Are institutional investors (FIIs/DIIs) increasing or selling down their stakes?

⚪ Neutral

Institutional Investor Activity

Based on the provided data, there is no direct information on FII/DII shareholding patterns. The data includes financial statements, ratios, and announcements but lacks quarterly shareholding patterns or institutional investor data. Therefore, it is not possible to determine whether institutional investors are increasing or selling down their stakes.

Data Limitation

The available sources do not contain shareholding pattern details. For such analysis, one would typically refer to the shareholding pattern section in quarterly reports or stock exchange filings, which are not included here.

⚪ Without specific shareholding data, investors cannot assess institutional sentiment. They should refer to quarterly shareholding patterns from stock exchange filings or the company's investor relations page.

CCL Products (India) Ltd (CCL): Is there any ongoing criminal or regulatory litigation against the promoters?

⚪ Neutral

No Evidence of Criminal or Regulatory Litigation

Based on the provided data, there is no mention of any ongoing criminal or regulatory litigation against the promoters of CCL Products (India) Ltd. The available source links include routine corporate announcements (e.g., ESOP allotments, investor meetings, trading window closures) and a clarification regarding volume movement, but none reference any litigation or legal proceedings involving promoters.

Data Limitation

The company data and source links do not contain any information about litigation, regulatory actions, or legal disputes. Therefore, it is not possible to confirm the absence or presence of such litigation from the given dataset.

⚪ Investors should note that while no litigation is evident from the provided data, this does not guarantee its absence. A thorough review of legal disclosures in annual reports or regulatory filings is recommended for a complete assessment.

CCL Products (India) Ltd (CCL): Does the promoter possess adequate domain experience to run this specialized business?

✅ Positive

[Promoter Background & Industry Experience]

The company's annual report states that CCL Products is engaged in the production, trading, and distribution of coffee, with operations in India, Vietnam, and Switzerland. The promoter's domain experience is not explicitly detailed in the provided data, but the company has been operating for decades and has shown consistent growth in sales and profits, indicating strong industry knowledge.

[Long-Standing Track Record]

The company has a 10-year compounded sales growth of 17% and profit growth of 12%, with a 5-year sales CAGR of 29% and profit CAGR of 16%. This sustained performance over a decade suggests that the management, including promoters, has deep expertise in the coffee business.

[Operational Consistency]

Operating profit margins have remained stable between 19-24% over the last five years (Mar 2015 to Mar 2019), and the company has maintained a healthy return on equity of 18% over 10 years. Such consistency in a specialized commodity business reflects adept management and domain proficiency.

✅ The promoter's long tenure and the company's consistent financial performance in the specialized coffee business indicate strong domain experience, which is a positive signal for investors.

CCL Products (India) Ltd (CCL): Are there regular insider buying activities by key management personnel?

⚪ Neutral

No Insider Trading Data Available

The provided data does not include any insider trading transactions or shareholding changes by key management personnel. The available sources are limited to corporate announcements, ESOP allotments, and investor meet intimation, none of which disclose insider buying activities.

ESOP Allotments Indicate Employee Incentives, Not Insider Buying

Recent announcements show allotment of 88,027 equity shares under the CCL Employee Stock Option Scheme 2022 (source: [Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS 4 Jun](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7ba69f21-74d8-471a-8556-5519b6831d83.pdf)) and 2,100 equity shares on 13.07.2026 (source: [Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS 2d](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ecd41653-d245-4d3e-91d6-48b687668f02.pdf)). These are ESOP exercises, not open market purchases by management.

No Regular Insider Buying Pattern Observed

Without insider transaction filings, it is not possible to confirm regular insider buying. The company's response to a volume movement clarification (source: [Reply To Clarification Related To Volume Movement](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e971c09a-0e6e-4594-b687-7838020a00a4.pdf)) states the movement is market-driven, with no company involvement, which does not address insider buying.

⚪ There is no evidence of regular insider buying by key management personnel based on available data. Investors should monitor insider transaction filings separately for signals of management confidence.

CCL Products (India) Ltd (CCL): What is the historical capital allocation track record?

🟡 Warning

[Capital Allocation: High Reinvestment & Rising Debt]

CCL has consistently reinvested heavily in capex, with fixed assets growing from ₹340 Cr (FY15) to ₹1,622 Cr (FY25) and CWIP from ₹53 Cr to ₹450 Cr. This expansion has been funded partly by debt, with borrowings rising from ₹229 Cr to ₹1,815 Cr over the same period, leading to a debt-to-equity ratio of 0.92 (FY25) vs. 0.54 (FY15).

[Free Cash Flow: Mostly Negative in Recent Years]

Free cash flow (FCF) has been negative in 5 of the last 6 years (FY18-FY23), with a particularly large negative FCF of -₹458 Cr in FY24. However, FY26 shows a sharp reversal to +₹788 Cr, suggesting a potential inflection point.

[Return on Capital: Stable but Not High]

ROCE has remained in the 15-16% range (15.82% as per key ratios), and ROE has been stable at ~18% over 10 years. While not exceptional, these returns are consistent and above the cost of capital.

[Dividend Payout: Moderate]

Dividend payout has averaged around 25% over the last 5 years (21-30%), indicating a balanced approach between reinvestment and shareholder returns.

🟡 CCL's aggressive capital spending has led to rising debt and negative free cash flow in most recent years, which is a concern. However, the sharp FCF improvement in FY26 and stable returns suggest the investments may be starting to pay off. Investors should monitor debt levels and cash flow sustainability.

🏭

Sector-Specific Analysis

15 questions

✅ 1 🔴 1

CCL Products (India) Ltd (CCL): Is the Loan Book (Advances) growing healthily? (Banking/NBFCs)

⚪ Neutral

Not Applicable – CCL Products is not a Banking/NBFC

CCL Products (India) Ltd operates in the Tea & Coffee industry, not in banking or financial services. The company does not maintain a loan book or advances portfolio. Its balance sheet shows borrowings (debt) on the liabilities side, not loans given to customers. Therefore, the question about loan book growth is not relevant for this company.

⚪ Since CCL Products is a coffee producer and trader, it does not have a loan book. Investors should focus on its core business metrics like sales growth, margins, and debt levels instead.

CCL Products (India) Ltd (CCL): Is the CASA Ratio improving? (Banking/NBFCs)

⚪ Neutral

Data Not Available

CCL Products (India) Ltd is a coffee trading and production company in the Fast Moving Consumer Goods sector, not a bank or NBFC. The CASA (Current Account Savings Account) ratio is a metric specific to banking and financial institutions and is not applicable to CCL's business model. No data on CASA ratio is available in the provided financials.

⚪ The question is not relevant to CCL Products as it operates in the FMCG sector (Tea & Coffee), not banking. Investors should focus on sector-specific metrics like sales growth, operating margins, and debt levels.

CCL Products (India) Ltd (CCL): What is the Net Interest Margin (NIM) trend? (Banking/NBFCs)

⚪ Neutral

Net Interest Margin (NIM) Trend

CCL Products (India) Ltd is a coffee trading and production company in the Fast Moving Consumer Goods sector, not a bank or NBFC. Therefore, Net Interest Margin (NIM) is not a relevant metric for this company.
The company's financial data does not include interest income or interest expense breakdowns that would allow calculation of NIM. The available data shows interest expenses (e.g., Rs. 8 Cr in Mar 2019) but no corresponding interest income, as the company's primary business is not lending.

Conclusion

NIM analysis is not applicable to CCL Products. Investors should focus on operating metrics like sales growth, operating profit margin, and return on equity instead.

⚪ Net Interest Margin is not a relevant metric for CCL Products as it is not a financial institution. Investors should evaluate the company using sector-appropriate ratios such as sales growth, OPM, and ROE.

CCL Products (India) Ltd (CCL): Are Gross NPA and Net NPA trends decreasing? (Banking/NBFCs)

⚪ Neutral

Data Not Available

The provided data does not include Gross NPA or Net NPA figures, as CCL Products (India) Ltd is a coffee trading and production company in the Fast Moving Consumer Goods sector, not a banking or NBFC entity. The question is sector-specific to banking/NBFCs and cannot be answered with the given data.

⚪ This question is not applicable to CCL Products as it operates in the FMCG sector (Tea & Coffee), not banking or NBFCs. No NPA data is available or relevant.

CCL Products (India) Ltd (CCL): What is the Return on Assets (ROA)? (Banking/NBFCs)

🔴 Red Flag

Return on Assets (ROA) Calculation

ROA is calculated as Net Profit / Total Assets. For the latest fiscal year (Mar 2026), Net Profit is not directly provided, but using the balance sheet total assets of ₹4,326 Cr and assuming net profit from annual data (not available for Mar 2026), we estimate ROA based on historical data. For Mar 2024, Net Profit was ₹155 Cr (from annual financials) and Total Assets were ₹3,536 Cr, giving an ROA of approximately 4.4%. For Mar 2023, Net Profit was ₹148 Cr and Total Assets ₹2,597 Cr, ROA ≈ 5.7%.
The trend shows declining ROA from 5.7% (Mar 2023) to 4.4% (Mar 2024), indicating lower asset efficiency.
Note: This is not a banking/NBFC company, so ROA is less commonly used; however, it is calculated for completeness.

🔴 The declining Return on Assets suggests that CCL Products is generating less profit per rupee of assets, which could indicate inefficiency or increased asset base without proportional profit growth. Investors should monitor asset utilization and profitability trends.

CCL Products (India) Ltd (CCL): What is the total dollar value of Deal Wins (TCV)? (IT Services)

⚪ Neutral

Data Not Available

The provided data does not include any information on Deal Wins or Total Contract Value (TCV), which are metrics specific to IT Services companies.
CCL Products (India) Ltd operates in the Tea & Coffee industry, not IT Services, so such metrics are not applicable.
No relevant data found in the available financial statements, ratios, or announcements.

⚪ This question is not applicable to CCL Products as it is not an IT Services company. Investors should focus on sector-specific metrics like sales growth, operating margins, and capacity expansion for this coffee producer.

CCL Products (India) Ltd (CCL): Is Employee Attrition increasing or decreasing? (IT Services)

⚪ Neutral

No Data Available

The provided company data does not include any information on employee attrition rates, headcount, or HR metrics. The financial statements, ratios, and disclosures focus on financial performance and operations, not on workforce statistics.

Sector Mismatch

CCL Products (India) Ltd operates in the Tea & Coffee industry (FMCG sector), not IT Services. Employee attrition is a key metric for IT services companies, but it is not typically disclosed or tracked in the same way for manufacturing/FMCG firms.

Conclusion

Without specific attrition data or relevant disclosures, it is impossible to determine whether employee attrition is increasing or decreasing for CCL Products.

⚪ Investors cannot assess employee attrition trends for CCL Products due to lack of data. This metric is more relevant for IT services companies, and the company's sector does not typically report such information.

CCL Products (India) Ltd (CCL): What is the Employee Utilization rate? (IT Services)

⚪ Neutral

Employee Utilization Rate Not Available

The provided data does not include employee headcount, billable hours, or utilization metrics specific to IT services. CCL Products (India) Ltd operates in the Tea & Coffee industry, not IT services, so employee utilization is not a standard metric for this sector.

⚪ Employee utilization rate is not applicable to CCL Products as it is a coffee trading and production company, not an IT services firm. Investors should focus on relevant operational metrics like capacity utilization or production efficiency instead.

CCL Products (India) Ltd (CCL): Are there any adverse USFDA inspection observations? (Pharma)

⚪ Neutral

Not Applicable

CCL Products (India) Ltd operates in the Tea & Coffee industry, not pharmaceuticals. Therefore, USFDA inspection observations are not relevant to this company.

⚪ Since CCL is not a pharmaceutical company, USFDA inspection observations do not apply. Investors should focus on sector-specific risks such as coffee price volatility and regulatory compliance in food processing.

CCL Products (India) Ltd (CCL): What percentage of revenue is directed toward R&D spend? (Pharma)

⚪ Neutral

No R&D Spend Data Available

The provided financial data for CCL Products (India) Ltd does not include any line item for research and development (R&D) expenditure. The company operates in the Tea & Coffee industry, which typically does not require significant R&D spending compared to pharmaceutical companies.

Industry Context

As a coffee producer and trader, CCL's competitive advantage lies in sourcing, processing, and distribution rather than R&D. Therefore, the absence of R&D data is expected and not a concern for this sector.

⚪ Since CCL is not a pharmaceutical company, the lack of R&D spend data is normal and does not impact its investment thesis. Investors should focus on operational efficiency and growth metrics instead.

CCL Products (India) Ltd (CCL): What is the underlying Volume Growth rate? (FMCG)

✅ Positive

Volume Growth Analysis

CCL Products' sales growth has been robust, with 3-year and 5-year compounded sales growth of 29% each, and TTM growth of 44% (source: Data Provider Company Profile). However, as a coffee producer, sales growth is a mix of volume and price/mix changes. The company does not disclose volume growth separately.
The company's operating profit margin (OPM) has remained stable around 21-24% over the last 5 years (annual financials), suggesting that sales growth is not purely price-driven. Stable margins imply that volume growth is likely a significant contributor to revenue expansion.
Given the lack of explicit volume data, we estimate volume growth to be in the range of 10-15% annually, based on industry trends and the company's capacity expansion (fixed assets grew from Rs. 383 Cr in Mar 2019 to Rs. 1,622 Cr in Mar 2025, balance sheet data).

✅ While exact volume growth is not disclosed, strong sales growth combined with stable margins and capacity expansion indicates healthy volume growth, which is positive for the company's long-term prospects.

CCL Products (India) Ltd (CCL): Is the product Premiumisation mix increasing? (FMCG)

⚪ Neutral

[Product Premiumisation Mix]

The provided data does not include segment-wise revenue breakdown by product type (e.g., premium vs. mass-market coffee) or average selling price trends. Without such granularity, it is not possible to directly assess whether the premiumisation mix is increasing.
However, the company's consistent sales growth (5-year CAGR of 29%) and improving operating profit margins (from 19% in FY15 to 23% in FY19) may indirectly suggest a shift toward higher-value products, but this is speculative.

[Data Limitation]

The available financials (annual, quarterly, balance sheet, cash flow) do not contain any specific metrics on product mix, premiumisation, or brand segmentation. Therefore, a definitive conclusion cannot be drawn from the given data.

⚪ Investors cannot determine the premiumisation trend from the provided data. Additional segment-wise revenue or pricing data is required to assess this aspect of the business.

CCL Products (India) Ltd (CCL): How fast is the Direct-to-Consumer (D2C) or E-commerce channel expanding? (FMCG)

⚪ Neutral

No Direct Data Available

The provided financial data does not include any segment-wise breakdown of revenue from Direct-to-Consumer (D2C) or e-commerce channels. The company's annual reports and quarterly filings do not disclose channel-wise revenue splits, making it impossible to quantify the expansion rate of D2C or e-commerce.

Indirect Indicators Suggest Growing Digital Presence

The company has been actively participating in investor conferences and virtual events (e.g., "CHAIRMAN, MD & CEO Virtual Investor Days" organized by Ashika Group), which may indicate a focus on digital engagement. However, this does not provide direct financial evidence of D2C/e-commerce growth.

Overall Sales Growth Suggests Broad-Based Expansion

Compounded sales growth of 29% over 3 years and 44% TTM (from provided growth metrics) indicates strong overall revenue growth, which could partially be driven by e-commerce, but no specific data is available to confirm.

⚪ Investors cannot assess the pace of D2C or e-commerce expansion from available data. The company's strong overall sales growth may include digital channels, but without disclosure, the contribution remains unknown. Seek additional management commentary or investor presentations for clarity.

CCL Products (India) Ltd (CCL): What is the Rural vs. Urban consumption split trend? (FMCG)

⚪ Neutral

Insufficient Data

The provided company data does not include any breakdown of sales or consumption by rural vs. urban segments. The financial statements, quarterly data, and annual reports focus on aggregate revenue, costs, and profitability without geographic or demographic segmentation. Therefore, a rural vs. urban consumption split trend cannot be derived from the available information.

⚪ Investors seeking to understand rural vs. urban consumption trends for CCL Products will need to look for additional disclosures or industry reports, as the company's financial data does not provide this granularity.

CCL Products (India) Ltd (CCL): Is the advertising and brand promotion spend stable? (FMCG)

⚪ Neutral

No Data Available

The provided financial data does not include any line item for advertising, marketing, or brand promotion expenses. The annual financials only show sales, expenses (aggregated), operating profit, other income, interest, depreciation, and net profit. Without a breakdown of selling, general, and administrative expenses, it is impossible to assess the stability or trend of advertising spend.

⚪ Investors cannot evaluate advertising spend stability from the available data. For a comprehensive analysis, refer to detailed annual reports or segment-wise expense disclosures.

🎯

Valuation & Final Investment Decisions

5 questions

✅ 1 🔴 2 🟡 2

CCL Products (India) Ltd (CCL): How does the current trailing Price-to-Earnings (P/E) ratio compare against its historical 5-year average?

🟡 Warning

Current Trailing P/E vs. Historical 5-Year Average

The current trailing P/E ratio is 41.09 (based on market cap of ₹15,947.51 Cr and TTM net profit of ~₹388 Cr, derived from stock PE). The 5-year average P/E is approximately 30.5 (estimated from historical price and earnings data).
The current P/E is about 35% higher than the 5-year average, indicating the stock is trading at a premium relative to its historical valuation.
This elevated P/E suggests that investor expectations for future growth are higher than the historical norm, which could be justified by the company's strong sales and profit growth (TTM sales growth 44%, profit growth 25%).

🟡 The stock is trading at a premium P/E compared to its 5-year average, which may indicate overvaluation if growth does not meet expectations. Investors should monitor whether the high growth rates are sustainable to justify the current valuation.

CCL Products (India) Ltd (CCL): What is the growth-adjusted valuation (PEG Ratio)?

🔴 Red Flag

PEG Ratio Calculation

Based on a P/E of 41.09 and a 3-year EPS CAGR of 11%, the PEG ratio is 41.09 / 11 = 3.74. Using 5-year EPS CAGR of 16%, PEG = 41.09 / 16 = 2.57. Using TTM EPS growth of 25%, PEG = 41.09 / 25 = 1.64.
All PEG ratios are above 1.0, indicating the stock is overvalued relative to its earnings growth, especially on longer-term growth rates.

Interpretation of PEG

A PEG > 1 suggests the market has priced in higher future growth than historical trends justify. The stock trades at a premium, which may limit upside unless growth accelerates.
The company's strong sales growth (29% 3-year CAGR) supports some premium, but the PEG remains elevated, signaling caution for value-focused investors.

🔴 The PEG ratio of 2.57 to 3.74 (depending on growth period) indicates the stock is trading at a premium to its earnings growth, suggesting limited margin of safety for investors seeking value.

CCL Products (India) Ltd (CCL): What is the Price-to-Book (P/B) ratio relative to the sector peers?

🔴 Red Flag

Current P/B Ratio

CCL Products (India) Ltd is currently trading at a Price-to-Book (P/B) ratio of approximately 6.78 (based on market cap of ₹15,947.51 crore and book value per share of ₹176, with face value ₹2 and 13.35 crore shares). This is significantly above the book value, indicating a premium valuation.

Sector Peer Comparison

The provided data does not include P/B ratios for sector peers. However, the company's P/B of 6.78 is high relative to typical FMCG companies, which often trade at P/B ratios between 3-5. The cons list repeatedly flags that the stock is trading at 6.35-6.92 times book value, suggesting consistent premium pricing.

Historical Context

Over the last 5 years, the company's book value per share has grown from ₹176 (Mar 2020) to ₹2318/13.35 ≈ ₹173.6 (Mar 2026), implying a P/B range of 6.9-6.8, which is elevated and may limit upside if growth slows.

🔴 The high P/B ratio relative to typical sector peers suggests the stock is priced at a premium, which could limit future returns if earnings growth does not justify the valuation. Investors should monitor whether the company's ROE and growth trajectory support this multiple.

CCL Products (India) Ltd (CCL): What could immediately break the primary investment thesis for this stock?

🟡 Warning

[Debt Surge and Deteriorating Interest Coverage]

Borrowings surged from Rs. 469 Cr (Mar 2020) to Rs. 1,815 Cr (Mar 2025), while interest coverage (operating profit / interest) fell from ~11.4x (Mar 2020) to ~4.3x (Mar 2025). A further rise in debt or interest rates could strain profitability and break the thesis of a low-risk, growing coffee player.

[Negative Free Cash Flow Trend]

Free cash flow has been negative for 5 of the last 6 years (e.g., -Rs. 458 Cr in Mar 2024, -Rs. 128 Cr in Mar 2025). Sustained negative FCF may force equity dilution or higher leverage, undermining the investment case.

[Declining Operating Cash Flow Quality]

Operating cash flow as a percentage of net profit dropped from ~109% (Mar 2020) to ~35% (Mar 2024), indicating weaker cash conversion. If this persists, reported earnings may not translate into cash, threatening dividend sustainability and growth funding.

[High Valuation Multiples]

Stock trades at ~6.8x book value and P/E of 41x, well above historical averages. Any earnings miss or slowdown in growth could trigger a sharp de-rating, breaking the thesis.

🟡 Investors should monitor debt levels, free cash flow, and cash conversion closely. A sustained deterioration in these metrics could invalidate the growth story and lead to significant downside.

100

CCL Products (India) Ltd (CCL): Is this business a long-term structural compounder or a tactical cyclical play?

✅ Positive

[Revenue & Profit Growth]

CCL has delivered a 10-year sales CAGR of 17% and a 5-year sales CAGR of 29%, with TTM sales growth accelerating to 44%. Profit growth has been more moderate at 12% over 10 years but improved to 25% TTM, indicating strong recent momentum.

[Return Ratios & Debt]

ROE has been stable at ~18% over 10 years, and ROCE is 15.82%, suggesting consistent capital efficiency. However, borrowings have risen sharply from Rs.229 Cr in FY15 to Rs.1,815 Cr in FY25, and free cash flow has been negative in most recent years due to heavy capex, raising leverage concerns.

[Valuation & Cyclicality]

The stock trades at a P/E of 41.09 and price-to-book of 6.48, which is elevated relative to historical averages. The coffee industry is subject to commodity price cycles, but CCL's long-term growth trajectory and expanding capacity suggest a structural compounder profile, albeit with cyclical risks.

✅ CCL exhibits characteristics of a long-term structural compounder with consistent revenue growth and stable returns, but rising debt and high valuation warrant caution. Investors should monitor debt levels and commodity cycles.